Trivisc

— THERAPEUTIC CATEGORIES —
  • Arthritis/rheumatic disorders

Trivisc Generic Name & Formulations

General Description

Sodium hyaluronate 10mg/mL; soln for intra-articular inj.

Pharmacological Class

Hyaluronan.

How Supplied

Single-use prefilled syringe—1

Manufacturer

Generic Availability

NO

Trivisc Indications

Indications

Treatment of pain in osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and simple analgesics (eg, acetaminophen).

Trivisc Dosage and Administration

Adult

Remove joint effusion, if present, before inj. Give as a single intra-articular inj. >21yrs: 2.5mL in one knee only at weekly intervals for 3 weeks. If bilateral, use separate syringes for each knee. May use SC lidocaine or similar local anesthetic prior to inj.

Children

≤21yrs: not established.

Trivisc Contraindications

Contraindications

Knee joint infections. Skin diseases in area of the inj site.

Trivisc Boxed Warnings

Not Applicable

Trivisc Warnings/Precautions

Warnings/Precautions

Effectiveness of a single treatment cycle of <3 injections or repeated treatment cycles: not established. Advise patients to avoid strenuous or prolonged weight-bearing activities for approx. 48hrs following inj. Pregnancy, nursing mothers: not established.

Trivisc Pharmacokinetics

See Literature

Trivisc Interactions

Interactions

Avoid use of disinfectants containing quaternary ammonium salts; hyaluronan can precipitate in their presence. Concomitant other intra-articular inj: not established.

Trivisc Adverse Reactions

Adverse Reactions

Inj site pain, allergic reaction, arthralgia, bleeding at the inj site, bleeding, heaviness; transient knee inflammation.

Trivisc Clinical Trials

See Literature

Trivisc Note

Not Applicable

Trivisc Patient Counseling

See Literature